Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
about
A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancerThyroid iodide efflux: a team effort?Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapyMolecular optical imaging with radioactive probes.Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancerSterol regulatory element-binding proteins are regulators of the NIS gene in thyroid cells.NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapySodium iodide symporter and the radioiodine treatment of thyroid carcinoma.The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells.Excess iodide decreases transcription of NIS and VEGF genes in rat FRTL-5 thyroid cellsThe effectiveness of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal prior to radioiodine remnant ablation in thyroid cancer: a meta-analysis of randomized controlled trialsFlavonoids, Thyroid Iodide Uptake and Thyroid Cancer-A Review.Intronic elements in the Na+/I- symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription.Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice.Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells.Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Molecular mechanisms of 2, 3', 4, 4', 5-pentachlorobiphenyl-induced thyroid dysfunction in FRTL-5 cellsRegulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cellsGlycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.Stimulation of cultured h9 human embryonic stem cells with thyroid stimulating hormone does not lead to formation of thyroid-like cells.Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways.Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.The biology of the sodium iodide symporter and its potential for targeted gene delivery.Regulation of iodide uptake in placental primary cultures.I-131 uptake in fat necrosis of the breast.Iodine mediated mechanisms and thyroid carcinoma.The prognosis and treatment of primary thyroid cancer occurred in breast cancer patients: comparison with ordinary thyroid cancer.Utility of single photon emission tomography/computed tomography in characterizing an additional focus of iodine uptake in post-treatment whole body iodine scan.The use of molecular imaging of gene expression by radiotracers in gene therapy.Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.Comparative analysis of protein-protein interactions in cancer-associated genes.Cholangiocarcinoma: from molecular biology to treatment.Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.
P2860
Q24643372-8DC5F502-F763-4A80-B9A0-7C2851439115Q26865962-FE78060C-0688-406C-94B3-6D3582907FCFQ28071977-71AC1CA9-4579-49CC-91DF-B1C060FDF8A8Q30979164-6BF2322B-31CE-46AC-B3F5-62703E94CAFFQ33603806-F93A469F-7F5A-4DDC-BF7F-137CE1E5D048Q33635793-DAC280DB-52D2-4A25-92BE-9FBD06D55F93Q33637267-5690A1E0-5522-4DF7-82F2-233B5742EA11Q33690729-F400310E-0656-4BF0-9E55-0615830A80F3Q33704207-60690FC6-7196-4401-BC85-B2DB7B5854DEQ33704634-3EBE9E59-0B45-4A06-9D1D-C39D3C4BA75BQ33712382-8BAF3119-1BC3-455B-B745-C56BF94AEE24Q33749205-1ADFD3A0-D1F9-4025-932B-AF5225D54783Q33838859-005C28B9-1D94-481A-BF5A-17068443A07AQ33889301-389B7FC0-AD76-4097-9A4B-65A69C586CCCQ33980777-35343E57-3C3E-40EF-B5EB-AA86F6C440B5Q34655846-0E4CCF28-2B35-4AA0-A685-C468E1A1260BQ34698684-C3DAE356-58A1-47B5-B176-30DAA28A6B13Q35196612-61349CB7-BE3E-4E13-95D5-53C7165C410FQ35728290-E7FAFFD2-FC15-4544-AC1E-9A32CE725E13Q35850033-B64185C8-3EF3-4169-9474-10A83652AA8EQ35949806-B123300D-8A71-4DE5-8E7A-7F1D265B2845Q36028914-981A363D-767F-4579-A592-6EBF02694752Q36128415-C3FC2987-3BE1-476F-B3E1-EFCCB213CA8BQ36337288-1E1E17B4-C5A6-404A-AC72-C6C12AEA604BQ36499907-63EE4457-800B-4593-B23F-845392ED2DA3Q36661121-36DF914E-DA1C-4989-85A2-8CBC9FF792B6Q37001327-08B996B3-F56F-4059-A746-BC922BBFC7EDQ37211959-DC52FED7-2CD1-40F1-836B-C596EA9BF17BQ37564872-486F89C7-5EB9-46FD-9E7B-6B4A9793C23EQ37582453-B15BA11D-433A-482B-B3EB-775F78D44444Q37643295-87885D88-21C9-4B61-A2AE-B3613CE49DB1Q37643737-1F2E0230-0840-4644-8923-410D35628285Q37718559-2E9A3325-BDE1-4640-8407-9D7C5643C0FCQ37718616-342C92E1-BB80-4C27-8364-EA76D15B8BDBQ37884052-70A4E452-D8A8-42F5-8FED-B60010387C0BQ38296989-53A0E779-45AF-47DB-A4B3-9C4C5A592036Q38509626-C8A1B577-A30C-440E-B9FA-DA2AD494B58EQ38597008-282CB7DE-817B-49FE-B486-0C34C5C68F81Q38730437-74527EF2-51A3-4F5D-BEE4-3D31CA78DF21Q39002421-3D6A2E45-76B9-4A2F-9046-54AA30F5F41E
P2860
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@ast
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@en
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@nl
type
label
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@ast
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@en
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@nl
prefLabel
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@ast
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@en
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@nl
P2093
P3181
P356
P1476
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
@en
P2093
P304
P3181
P356
10.1677/ERC.1.01143
P407
P577
2006-09-01T00:00:00Z